| Adherens junction protein nectin-4 is the epithelial receptor for measles virus MD Mühlebach, M Mateo, PL Sinn, S Prüfer, KM Uhlig, VHJ Leonard, ... Nature 480 (7378), 530-533, 2011 | 664 | 2011 |
| In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges B Turoňová, M Sikora, C Schürmann, WJH Hagen, S Welsch, FEC Blanc, ... Science 370 (6513), 203-208, 2020 | 599 | 2020 |
| Targeted cell entry of lentiviral vectors S Funke, A Maisner, MD Mühlebach, U Koehl, M Grez, R Cattaneo, ... Molecular Therapy 16 (8), 1427-1436, 2008 | 258 | 2008 |
| Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus P Bach, T Abel, C Hoffmann, Z Gal, G Braun, I Voelker, CR Ball, ... Cancer research 73 (2), 865-874, 2013 | 147 | 2013 |
| DARPins: an efficient targeting domain for lentiviral vectors RC Münch, MD Mühlebach, T Schaser, S Kneissl, C Jost, A Plückthun, ... Molecular Therapy 19 (4), 686-693, 2011 | 141 | 2011 |
| High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus VA Scheuplein, J Seifried, AH Malczyk, L Miller, L Höcker, J Vergara-Alert, ... Journal of virology 89 (7), 3859-3869, 2015 | 134 | 2015 |
| A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform AH Malczyk, A Kupke, S Prüfer, VA Scheuplein, S Hutzler, D Kreuz, ... Journal of virology 89 (22), 11654-11667, 2015 | 132 | 2015 |
| The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection L Henss, A Auste, C Schürmann, C Schmidt, C von Rhein, MD Mühlebach, ... Journal of General Virology 102 (4), 001574, 2021 | 111 | 2021 |
| A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine C Hörner, C Schürmann, A Auste, A Ebenig, S Muraleedharan, ... Proceedings of the National Academy of Sciences 117 (51), 32657-32666, 2020 | 88 | 2020 |
| DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety K Friedrich, JRH Hanauer, S Prüfer, RC Münch, I Völker, C Filippis, C Jost, ... Molecular Therapy 21 (4), 849-859, 2013 | 86 | 2013 |
| Lentiviral vectors with measles virus glycoproteins–dream team for gene transfer? CJ Buchholz, MD Mühlebach, K Cichutek Trends in biotechnology 27 (5), 259-265, 2009 | 84 | 2009 |
| Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity S Funke, IC Schneider, S Glaser, MD Mühlebach, T Moritz, R Cattaneo, ... Gene therapy 16 (5), 700-705, 2009 | 75 | 2009 |
| Vaccine platform recombinant measles virus MD Mühlebach Virus genes 53 (5), 733-740, 2017 | 68 | 2017 |
| A measles virus-based vaccine candidate mediates protection against Zika virus in an allogeneic mouse pregnancy model C Nürnberger, BS Bodmer, AH Fiedler, G Gabriel, MD Mühlebach Journal of virology 93 (3), 10.1128/jvi. 01485-18, 2019 | 67 | 2019 |
| Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both … BS Bodmer, AH Fiedler, JRH Hanauer, S Prüfer, MD Mühlebach Virology 521, 99-107, 2018 | 51 | 2018 |
| Measles virus-based treatments trigger a pro-inflammatory cascade and a distinctive immunopeptidome in glioblastoma S Rajaraman, D Canjuga, M Ghosh, MC Codrea, R Sieger, F Wedekink, ... Molecular Therapy-Oncolytics 12, 147-161, 2019 | 49 | 2019 |
| Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles VirusMMP-Activatable Measles Virus in Liver … MD Mühlebach, T Schaser, M Zimmermann, S Armeanu, ... Cancer research 70 (19), 7620-7629, 2010 | 45 | 2010 |
| APOBEC4 Enhances the Replication of HIV-1 D Marino, M Perković, A Hain, AA Jaguva Vasudevan, H Hofmann, ... PloS one 11 (6), e0155422, 2016 | 43 | 2016 |
| Stable transduction of primary human monocytes by simian lentiviral vector PBj MD Mühlebach, N Wolfrum, S Schüle, U Tschulena, R Sanzenbacher, ... Molecular Therapy 12 (6), 1206-1216, 2005 | 43 | 2005 |
| A novel lentivirus vector derived from apathogenic simian immunodeficiency virus J Stitz, MD Mühlebach, U Blömer, M Scherr, M Selbert, P Wehner, S Steidl, ... Virology 291 (2), 191-197, 2001 | 42 | 2001 |
